VRNA — Verona Pharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid CapNeutral
- $643.63m
- $537.10m
- $40.00m
Annual cashflow statement for Verona Pharma, fiscal year end - December 31st, millions except per share.
2017 December 31st | 2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | ||
| Standards: | — | — | USG | USG | USG |
| Status: | fx Preliminary | fx Preliminary | Final | Final | Final |
| Net Income/Starting Line | — | — | -40.6 | -65.1 | -55.6 |
| Depreciation | |||||
| Non-Cash Items | — | — | 1.45 | 21.6 | 23.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | — | -4.27 | -2.11 | -1.56 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | — | — | -42.9 | -45.1 | -33.3 |
| Capital Expenditures | — | — | -0.053 | -0.082 | -0.012 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 47.4 | 9.79 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | — | 47.3 | 9.71 | -0.012 |
| Financing Cash Flow Items | — | — | 0 | -12.9 | -6.85 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | 0 | 192 | -6.12 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | — | 5.18 | 158 | -39.6 |